1. Brown, N. et al. Artificial intelligence in chemistry and drug design. J. Comput. Aided Mol. Des. 34, 709–715 (2020).
2. Kopp, E. BioXCel Therapeutics announces FDA approval of IGALMI™ (dexmedetomidine) sublingual film for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. BioXcel Therapeutics (6 April 2022).
3. Savage, N. Drug discovery companies are customizing ChatGPT: here’s how. Nat. Biotechnol. 41, 585–586 (2023).
4. Joachim, B., Rehm, W., Ryan, S. & Wright, P. A biotech survival kit for a challenging public-market environment. McKinsey (19 September 2022).
5. Leclerc, O., Suhendra, M. & The, L. What are the biotech investment themes that will shape the industry? McKinsey (10 June 2022).